Related Experiment Video
Updated: May 29, 2026
08:54
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Barrett's esophagus registries
Piers A C Gatenby1, Christine P J Caygill, Anthony Watson
1Division of Surgery and Interventional Science, University College London, London, United Kingdom.
Annals of the New York Academy of Sciences
|September 29, 2011
Summary
This study compares Barrett's esophagus registries in the US and Europe, highlighting data, organization, and patient differences. Collaborative research is crucial for advancing understanding and treatment of this esophageal condition.
Area of Science:
- Gastroenterology and Esophageal Research
- Comparative Health Systems Analysis
Background:
- Barrett's esophagus is a significant risk factor for esophageal adenocarcinoma.
- Existing registries offer valuable data but vary in scope and structure.
Purpose of the Study:
- To analyze and compare key components of Barrett's esophagus registries in the United States and Europe.
- To identify differences in data sets, organizational structures, and patient demographics.
- To emphasize the value of international collaboration in Barrett's esophagus research.
Main Methods:
- Comparative analysis of existing Barrett's esophagus registries.
- Review of data inclusion criteria, organizational frameworks, and demographic information.
- Discussion of lifestyle and diagnostic variations between regions.
Main Results:
- Identified significant differences in data set composition and organizational approaches between US and European registries.
- Highlighted variations in demographic profiles, lifestyle factors, and diagnostic practices.
- Underscored the need for standardized methodologies in collaborative studies.
Conclusions:
- International collaboration is essential for robust Barrett's esophagus research.
- Addressing registry disparities can improve data quality and comparability.
- Further joint efforts are needed to advance the understanding and management of Barrett's esophagus.
Related Concept Videos
01:21Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:24Esophagus
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:25Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...